Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,176 | 130 | 68.8% |
| Travel and Lodging | $909.89 | 6 | 28.8% |
| Education | $76.49 | 1 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $782.54 | 10 | $0 (2022) |
| Boston Scientific Corporation | $664.00 | 7 | $0 (2024) |
| ABBVIE INC. | $412.88 | 41 | $0 (2024) |
| Allergan, Inc. | $338.35 | 23 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $151.70 | 8 | $0 (2024) |
| UCB, Inc. | $139.99 | 8 | $0 (2024) |
| Eisai Inc. | $136.29 | 8 | $0 (2024) |
| Celgene Corporation | $85.85 | 6 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $62.05 | 3 | $0 (2021) |
| Alexion Pharmaceuticals, Inc. | $54.58 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $469.47 | 25 | Teva Pharmaceuticals USA, Inc. ($136.92) |
| 2023 | $324.20 | 13 | Boston Scientific Corporation ($132.28) |
| 2022 | $1,234 | 41 | Medtronic, Inc. ($782.54) |
| 2021 | $1,135 | 58 | Boston Scientific Corporation ($509.83) |
All Payment Transactions
137 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Neurology | ||||||
| 12/05/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $14.90 | General |
| 11/26/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: Neurology | ||||||
| 11/19/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Neurology | ||||||
| 11/01/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Neurology | ||||||
| 10/30/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $10.48 | General |
| Category: Central Nervous System | ||||||
| 10/23/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Neurology | ||||||
| 10/15/2024 | Azurity Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $23.97 | General |
| 10/08/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Central Nervous System | ||||||
| 07/10/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Neurology | ||||||
| 06/24/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $28.97 | General |
| Category: NEUROSCIENCE | ||||||
| 06/20/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $7.57 | General |
| Category: Central Nervous System | ||||||
| 06/03/2024 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $76.49 | General |
| 05/15/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $22.33 | General |
| Category: NEUROLOGY | ||||||
| 05/13/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Neurology | ||||||
| 05/09/2024 | PFIZER INC. | VYNDAMAX (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/03/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $4.34 | General |
| Category: Central Nervous System | ||||||
| 04/24/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: PAIN | ||||||
| 03/28/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Central Nervous System | ||||||
| 03/13/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Neurology | ||||||
| 03/07/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Neurology | ||||||
| 03/06/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 02/14/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Neurology | ||||||
| 02/09/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $3.89 | General |
| Category: Central Nervous System | ||||||
| 01/08/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 164 | 216 | $69,585 | $20,887 |
| 2022 | 11 | 501 | 1,784 | $142,952 | $57,164 |
| 2021 | 5 | 244 | 265 | $62,482 | $28,756 |
| 2020 | 5 | 197 | 220 | $47,019 | $20,264 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 46 | 79 | $27,255 | $8,559 | 31.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 58 | 58 | $24,650 | $7,305 | 29.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 43 | 61 | $15,250 | $4,668 | 30.6% |
| 72110 | X-ray of lower and sacral spine, minimum of 4 views | Office | 2023 | 17 | 18 | $2,430 | $355.45 | 14.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 176 | 198 | $51,678 | $21,106 | 40.8% |
| J0587 | Injection, rimabotulinumtoxinb, 100 units | Office | 2022 | 22 | 1,270 | $22,860 | $12,242 | 53.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 133 | 140 | $27,080 | $10,992 | 40.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 23 | 23 | $8,929 | $3,312 | 37.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 50 | 51 | $6,625 | $2,732 | 41.2% |
| 64611 | Injection of chemical for paralysis of salivary glands on both sides of mouth | Office | 2022 | 31 | 31 | $8,959 | $2,220 | 24.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $4,160 | $1,468 | 35.3% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2022 | 11 | 11 | $5,670 | $1,268 | 22.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $1,870 | $718.61 | 38.4% |
| 95983 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | Office | 2022 | 17 | 22 | $3,366 | $708.09 | 21.0% |
| 72110 | X-ray of lower and sacral spine, minimum of 4 views | Office | 2022 | 13 | 13 | $1,755 | $396.08 | 22.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 124 | 138 | $34,310 | $15,794 | 46.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 76 | 83 | $14,094 | $6,853 | 48.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 18 | 18 | $5,814 | $2,414 | 41.5% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 13 | 13 | $4,972 | $2,362 | 47.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $3,292 | $1,333 | 40.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 92 | 113 | $18,601 | $7,813 | 42.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 46 | 46 | $11,524 | $4,948 | 42.9% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2020 | 17 | 17 | $6,110 | $2,711 | 44.4% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2020 | 22 | 22 | $5,896 | $2,666 | 45.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 20 | 22 | $4,888 | $2,126 | 43.5% |
About Todd Ramer, CNS
Todd Ramer, CNS is a Clinical Nurse Specialist healthcare provider based in Choctaw, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/28/2009. The National Provider Identifier (NPI) number assigned to this provider is 1013142462.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Todd Ramer, CNS has received a total of $3,162 in payments from pharmaceutical and medical device companies, with $469.47 received in 2024. These payments were reported across 137 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,176).
As a Medicare-enrolled provider, Ramer has provided services to 1,106 Medicare beneficiaries, totaling 2,485 services with total Medicare billing of $127,072. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Clinical Nurse Specialist
- Other Specialties Neuroscience, Acute Care
- Location Choctaw, OK
- Active Since 05/28/2009
- Last Updated 08/04/2025
- Taxonomy Code 364S00000X
- Entity Type Individual
- NPI Number 1013142462
Products in Payments
- PERCEPT PC BRAINSENSE (Device) $764.18
- GENERAL - DBS (Device) $509.83
- BOTOX (Biological) $435.29
- QULIPTA (Drug) $179.83
- WaveWriter Alpha Prime 16 (Device) $154.17
- UBRELVY (Drug) $136.11
- ZEPOSIA (Drug) $119.59
- Leqembi (Drug) $118.29
- Briviact (Drug) $77.32
- Nayzilam (Drug) $62.67
- AJOVY (Biological) $41.20
- Soliris (Drug) $37.91
- Dhivy (Drug) $36.63
- Nourianz (Drug) $29.23
- VYEPTI (Biological) $22.33
- WAKIX (Drug) $22.17
- Austedo XR (Drug) $19.23
- Nuedexta (Drug) $18.74
- KYPHON EXPRESS II KYPHOPAK TRAY (Device) $18.36
- Aduhelm (Drug) $18.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.